Patient description: Patient is a 34-year-old woman from Jordan who comes to clinic with some general and non-specific bones and joints pain. She is married and has 3 children. Her past medical and drug history are unremarkable. Her BMI is 23, BP: 120/75, HR: 75/min. Her laboratory study is remarkable for Vit D: 14ng/ml and otherwise healthy. (Ca: 9.2mg/dl, Phosphorus: 3.2mg/dl, PTH: 28pg/ml)

Clinical trial eligibility criteria: eligible ages (years): 2.0-100.0,  Dermatomyositis Polymyositis Inclusion Body Myositis Patients with Myositis: All patients should have age range 2 years. All Patients admitted to the study must satisfy at least one of the following among item 1 (A or B or C) OR item 2 (A or B or C) AND item 3: 1. Patient has documented evidence that he/she meets for an idiopathic inflammatory myopathy A. Possible, probable or definite adult or juvenile polymyositis or dermatomyositis by Bohan and Peter B. Possible, probable or definite body myositis by Griggs and/or ENMC C. Has an idiopathic inflammatory myopathy that does not meet these including common or rarer forms of myositis such as cancer associated, focal, orbital, eosinophilic myositis, macrophagic, proliferative, etc. 2. Has one of the following conditions: 2A. Have a disorder that is related to an idiopathic inflammatory myopathy, that may Inflammatory and non-inflammatory myopathies Mimicking and related skin disorders Disorders of the complications of myositis (including interstitial lung disease, calcifying disorders, cardiomyopathies, etc.) Overlapping autoimmune diseases that may be associated with myositis Patients with muscle and/or skin inflammation and documented environmental exposures Patients with myositis or complications of myositis and suspected genetic disorders Patients with undifferentiated connective tissue disease  Patients <2 years or >100 years will be excluded. 2. Any conditions in which the drawing of the amount of blood required or undergoing procedures needed for the study is not deemed medically appropriate by the treating physician or the principal investigator.] For females of childbearing potential who are pregnant, they will be permitted to enroll, but would be excluded from radiographic procedures involving radiation or greater than minimal risk procedures, including obtaining biopsies. Relatives of Patients with Myositis: For patients with at least one first-degree relative affected with IIIM, all available first-degree relatives (affected and unaffected) are eligible to participate in the genetics portion of the protocol. For patients in which two or more first degree relatives are affected with myositis, any available close relatives (affected or unaffected parents, siblings or children, as well as grandparents and grandchildren, or other close relatives, when available) are eligible to participate in the genetics portion of the protocol. 1. First or more distant relative of a proband with myositis, for genetics studies. 2. Ability of patient or parent/guardian to give informed consent to all or part of the study after full information has been provided Patients <2 years or >100 years will be excluded. 2. Any conditions in which the drawing of the amount of blood required or undergoing procedures needed for the study is not deemed medically appropriate by the treating physician or the principal investigator. 3. Pregnancy (females of child-bearing potential). Verbal confirmation they are not pregnant. Healthy Volunteers: 1. Healthy volunteer subjects for biomarker studies will be gender and age-matched (within 5 years) with a myositis patient, as reasonably close as possible. 2. Volunteer is not related to a myositis patient who is enrolled in the study 3. Volunteer is in good health, without a recognized systemic rheumatic disorder, autoimmune disease, immune medicated disease, or cancer, and is not taking any anti-inflammatory medicines, including nonsteroidal anti-inflammatory drugs (NSAIDS) or corticosteroids 4. Volunteer or volunteer s parent/guardian could give assent/informed consent to all or part of the study after full information has been provided If Any Yes answer patient is not eligible for study 1. Volunteer has undergone surgery or had a major trauma within the past 2 months 2. Volunteer used anti-inflammatory medications within the past 8 weeks of enrollment, including not currently receiving nonsteroidal anti-inflammatory drugs or corticosteroids 3. Volunteer has been diagnosed with a chronic infectious illness, inflammatory disease, malignancy, cardiac or pulmonary disease, muscle disorder, clotting disorder, metabolic disorder, systemic rheumatic or autoimmune disease, or immune-mediated disease 4. Volunteer is pregnant (verbally screened for females of child-bearing potential) 5. Volunteer has a medical illness that in the judgement of the investigators does not allow safe blood draws or other clinical evaluations needed for study participation 6. Volunteer is cognitively impaired 7. Volunteer and or the volunteer s parents/legal guardian is unable or unwilling to give informed consent/assent 8. Volunteer has functional limitations 9. Volunteer has joint or muscle problems Note that the following screening activities may be performed to determine subject Email, written, or telephone communications with prospective subjects Review of existing medical records Review of existing imaging studies Review of existing photographs or videos Review of existing pathology specimens/reports from a specimen obtained for diagnostic purposes